News

Lifespan of glucose-controlling molecule could be extended, helping protect against obesity, research suggests
Between 1990 and 2017 the global deaths attributed to high body mass index more than doubled from 2.2 million to 4.7 million ...
Hotter and drier climate in Colorado's San Luis Valley contributes to kidney disease in agriculture workers
Heat and humidity contributed to kidney damage and disease in the San Luis Valley in Colorado between 1984 and 1998, ...
Many young adults have high long-term risk for cardiovascular disease, study finds
A recent Northwestern Medicine study published in JAMA has found that 1 in 7 U.S. adults between the ages of 30 and 59 years ...
Multisociety recommendation urges strengthening of infection prevention and control programs in health care facilities
The Society for Health care Epidemiology of America (SHEA), in collaboration with the Association for Professionals in ...
Children with liver disease face dramatically higher risk of early death
Researchers from the University of California San Diego have found that children diagnosed with metabolic ...
Data collection changes key to understanding maternal mortality trends in the US, study shows
A new study led by researchers at the University of Oxford, published in JAMA Pediatrics, offers fresh insight into trends in ...
Understanding sudden unusual mental or somatic experiences
Matthew Sacchet, Ph.D., Director of the Meditation Research Program at Massachusetts General Hospital and an Associate ...
Olaparib and pembrolizumab combination shows early promise in molecularly selected, tumor-agnostic trial
The combination of the PARP inhibitor olaparib and the PD-1 inhibitor pembrolizumab showed initial antitumor activity with no new safety signals in a molecularly matched, tumor-agnostic trial, ...
Topical gel relieves painful skin rash side effect caused by targeted therapy for colorectal cancer
A new topical gel called LUT014 successfully reduced the severity of a painful acne‐like rash that commonly occurs as a side effect of targeted therapy with epidermal growth factor receptor (EGFR) ...